Drug intelligence / Profile preview

clinacanthus nutans

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Clinacanthus nutans, commonly known as Sabah snake grass, is a perennial herb in the family Acanthaceae native to tropical Southeast Asia. Traditionally utilized in folk medicine for treating snake bites, insect stings, and skin conditions like herpes zoster and rashes, it has gained significant research interest for its broad pharmacological profile. The plant is rich in bioactive compounds including C-glycosyl flavones (such as schaftoside, vitexin, and isovitexin), phenolic acids, and polysaccharides. Its therapeutic effects are largely attributed to its anti-inflammatory, antioxidant, and antiviral properties. Mechanistically, extracts from Clinacanthus nutans inhibit pro-inflammatory mediators like cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), often through the suppression of the NF-κB signaling pathway. Furthermore, it has demonstrated potential in oncology by inducing apoptosis and inhibiting cell proliferation in various cancer cell lines, including breast, lung, cervical, and colon cancer. It also exhibits renoprotective and antihypertensive activities by modulating the ROS/NF-κB/MMP-9 and eNOS/NO pathways.

Other names
Sabah snake grassBelalai GajahDalingdingPhaya YoClinacanthus nutans (Burm.f.) Lindau
02

Targets

BCL-2 (BCL-2 family)CASP3 (Caspase-3)CASP8 (Caspase-8)CASP9 (Caspase-9)MDM2 (Mouse double minute 2 homolog)MMP9 (Matrix metalloproteinase-9)NOS2 (Nitric Oxide Synthase 2)NF-κBPTGS2 (Prostaglandin-Endoperoxide Synthase 2)AMPK (Adenosine monophosphate–activated protein kinase)Sucrase-IsomaltasePDE3B (Phosphodiesterase 3B)

Beyond the preview

Go deeper on clinacanthus nutans.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clinacanthus nutans.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call